Exploring The Power of Smarter Segmentation

How smart segmentation is redefining pharma engagement in 2025

Elevate Healthcare was featured in the June 2025 issue of PM360 to share our take on how modern segmentation strategies are transforming engagement across the pharmaceutical industry. In the article, “The Importance of Segmentation in Marketing Plans for 2025,” we explore how AI-powered insights are helping marketers move beyond broad audience definitions and cater to further segmented groups.

Today, it’s all about precision and really taking the time to understand the motivations, behaviors, and decision-making patterns of high-value customer segments.

By diving deeper into demographics, psychographics, geography, and behavior, brands can craft more relevant, personalized messaging that drives stronger engagement and loyalty. As digital ad spends climb past $526 billion globally, every percentage point of improved targeting has impact.

The article also features a real-world case study about a biopharma brand that used advanced segmentation to stay ahead of competitors, despite the premium price tag. Their success highlights how tailored strategies can future-proof a brand in competitive markets. At Elevate, we believe segmentation is no longer an optional add-on, but an essential strategy. With the right strategy and tools, it has the power to be a driver of brand growth and differentiation.

Read the full article in the June issue of PM360 here.